Pip Nicolson/X
Jun 6, 2025, 10:56
Pip Nicolson Highlights Key PITT Case Insight on Anti-PF4 Antibody Testing
Pip Nicolson, Associate Clinical Professor in Cardiovascular Medicine (Haematology) at University of Birmingham, shared on X:
“Thank you Prof. Makris for your clear and concise commentary on our PITT case in the British Journal of Hematology.
Take home message: test anyone with the combination of thrombosis and thrombocytopenia for anti-PF4 antibodies (by ELISA) and have a low threshold for starting non-heparin anticoagulation.”
You Can Find More Posts Featuring Pip Nicolson on Hemostasis Today.
Title: PF4-associated immune thrombocytopenia and thrombosis (PITT)—More than heparin and vaccines
Author: Michael Makris
-
Jul 21, 2026, 01:28Dhamirah Nazihah Mohd Nasiruddin: A Milestone in My Haemostasis and Thrombosis Journey at ISTH 2026
-
Jul 21, 2026, 00:55Anita Brikman on PPTA’s First-Half 2026 Achievements
-
Jul 21, 2026, 00:50Caitlin Raymond: Can Therapeutic Plasma Exchange Reduce Microplastics?
-
Jul 21, 2026, 00:46Yohei Hisada: Science, Collaboration, and New Beginnings at ISTH 2026
-
Jul 21, 2026, 00:41Ahmed Koriesh: Inside Our 2026 Stroke Simulation Lab
-
Jul 20, 2026, 21:17Connie Montgomery: Building Community Through the HFA Black Voices Summit
-
Jul 20, 2026, 21:15Leonie Bolt: Honored to Present on Coronary Artery Calcium Scoring in Hemophilia A at ISTH 2026
-
Jul 20, 2026, 21:12Mihir Jain: Can Gene Therapy Transform Hemophilia Care in India?
-
Jul 20, 2026, 21:10Mohammed W. Badri: Are We Doing Enough to Prevent Life-Threatening Bleeds in Children?